| Ocean Miranda Brewer, APRN-CNP | |
|
1210 Dequeen St, Mena, AR 71953-4132 | |
| (479) 394-5068 | |
| (479) 394-5626 |
| Full Name | Ocean Miranda Brewer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1210 Dequeen St, Mena, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184254765 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LX0001X | Nurse Practitioner - Obstetrics & Gynecology | 123653 (Arkansas) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 123653 (Arkansas) | Primary |
| Entity Name | Ouachita Family Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225289978 PECOS PAC ID: 4385705789 Enrollment ID: O20081203000755 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that the U.S. Patent & Trademark Office has issued U.S. Patent 7,833,998 entitled, Oral Neurotherapeutic Cephalosporin Sulfoxide and Sulfone-containing Compositions.
The Breaking the Rules, Stretching the Rules 2004 monitoring report analyses the promotional practices of 16 transnational baby food companies and 14 bottle and teat companies between January 2002 and April 2004. The benchmark standards used for measuring marketing practices are the International Code of Marketing of Breastmilk Substitutes and subsequent, relevant World Health Assembly (WHA) Resolutions.
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
Northeast Ohio Medical University researcher and professor of anatomy and neurobiology Jianxin Bao, Ph.D., has received a large federal grant to produce the first human treatment for tinnitus, a disruptive hearing impairment marked by the perception of ringing or buzzing in one or both ears.
The results, in press with NeuroImage, show that sex hormones alter the development of certain brain structures during puberty and that these effects persist into adulthood.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ocean Miranda Brewer, APRN-CNP 1210 Dequeen St, Mena, AR 71953-4132 Ph: (479) 394-5068 | Ocean Miranda Brewer, APRN-CNP 1210 Dequeen St, Mena, AR 71953-4132 Ph: (479) 394-5068 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that the U.S. Patent & Trademark Office has issued U.S. Patent 7,833,998 entitled, Oral Neurotherapeutic Cephalosporin Sulfoxide and Sulfone-containing Compositions.
The Breaking the Rules, Stretching the Rules 2004 monitoring report analyses the promotional practices of 16 transnational baby food companies and 14 bottle and teat companies between January 2002 and April 2004. The benchmark standards used for measuring marketing practices are the International Code of Marketing of Breastmilk Substitutes and subsequent, relevant World Health Assembly (WHA) Resolutions.
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
Northeast Ohio Medical University researcher and professor of anatomy and neurobiology Jianxin Bao, Ph.D., has received a large federal grant to produce the first human treatment for tinnitus, a disruptive hearing impairment marked by the perception of ringing or buzzing in one or both ears.
The results, in press with NeuroImage, show that sex hormones alter the development of certain brain structures during puberty and that these effects persist into adulthood.
› Verified 8 days ago
Terri L Barrada, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 136 Health Park Dr, Mena, AR 71953 Phone: 888-710-8220 Fax: 866-573-0761 | |
Gretchen Laurel Goodnight, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 403 Morrow St N Ste D, Mena, AR 71953 Phone: 479-437-6080 Fax: 479-437-6079 | |
Lindy Kaye Jumper, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 136 Health Park Dr, Mena, AR 71953 Phone: 888-710-8220 Fax: 866-573-0761 | |
Kimberly Diane Nance, APRN, BC, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1706 Highway 71 N, Mena, AR 71953 Phone: 479-394-4800 Fax: 479-394-4805 | |
Sandy Morgan, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1706 Highway 71 N, Mena, AR 71953 Phone: 479-394-1500 Fax: 479-394-1525 | |
Mrs. Debra Inevia Fairless, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1210 Dequeen St, Mena, AR 71953 Phone: 479-394-5068 Fax: 479-394-5626 |